Characterization and reproducibility of HepG2 hanging drop spheroids toxicology in vitro.

Hepatotoxicity remains a major challenge in drug development despite preclinical toxicity screening using hepatocytes of human origin. To overcome some limitations of reproducing the hepatic phenotype, more structurally and functionally authentic cultures in vitro can be introduced by growing cells in 3D spheroid cultures. Characterisation and reproducibility of HepG2 spheroid cultures using a high-throughput hanging drop technique was performed and features contributing to potential phenotypic variation highlighted. Cultured HepG2 cells were seeded into Perfecta 3D® 96-well hanging drop plates and assessed over time for morphology, viability, cell cycle distribution, protein content and protein-mass profiles. Divergent aspects which were assessed included cell stocks, seeding density, volume of culture medium and use of extracellular matrix additives. Hanging drops are advantageous due to no complex culture matrix being present, enabling background free extractions for downstream experimentation. Varying characteristics were observed across cell stocks and batches, seeding density, culture medium volume and extracellular matrix when using immortalized HepG2 cells. These factors contribute to wide-ranging cellular responses and highlights concerns with respect to generating a reproducible phenotype in HepG2 hanging drop spheroids.

[1]  S. Fey,et al.  Determination of Drug Toxicity Using 3D Spheroids Constructed From an Immortal Human Hepatocyte Cell Line , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  Terry S Peters,et al.  Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials? , 2005, Toxicologic pathology.

[3]  Christopher S. Chen,et al.  Engineering cellular microenvironments to improve cell-based drug testing. , 2002, Drug discovery today.

[4]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[5]  Bruno Sarmento,et al.  An evaluation of the latest in vitro tools for drug metabolism studies , 2014, Expert opinion on drug metabolism & toxicology.

[6]  Leming Shi,et al.  Similarities and Differences in the Expression of Drug-Metabolizing Enzymes between Human Hepatic Cell Lines and Primary Human Hepatocytes , 2011, Drug Metabolism And Disposition.

[7]  W. M. Lee,et al.  Drug-induced hepatotoxicity. , 1995, The New England journal of medicine.

[8]  F. Pampaloni,et al.  The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.

[9]  G. Darlington,et al.  Modulation of the liver specific phenotype in the human hepatoblastoma line Hep G2 , 1989, In Vitro Cellular & Developmental Biology.

[10]  Jyrki Lötjönen,et al.  A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses , 2010, PloS one.

[11]  S. Takayama,et al.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[12]  F. Noor,et al.  Organotypic Cultures of Hepg2 Cells for In Vitro Toxicity Studies , 2011 .

[13]  Genee Y. Lee,et al.  The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.

[14]  JONG BIN Kim,et al.  Three-dimensional tissue culture models in cancer biology. , 2005, Seminars in cancer biology.

[15]  José Vicente Castell,et al.  Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo. , 2007, Chemico-biological interactions.

[16]  A. Ivascu,et al.  Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis , 2006, Journal of biomolecular screening.

[17]  R. Andrade,et al.  Drug-induced hepatotoxicity , 2003, The New England journal of medicine.

[18]  C. Selden,et al.  What keeps hepatocytes on the straight and narrow? Maintaining differentiated function in the liver , 1999, Gut.

[19]  Jung-Woog Shin,et al.  Potential of engineering methodologies for the application to pharmaceutical research , 2012, Archives of pharmacal research.

[20]  L. Kunz-Schughart,et al.  Multicellular tumor spheroids: an underestimated tool is catching up again. , 2010, Journal of biotechnology.

[21]  J. M. Ryan,et al.  The influence of culture medium volume on cell density and lifespan of human diploid fibroblasts. , 1975, Experimental cell research.

[22]  S. Fey,et al.  The Cultural Divide: Exponential Growth in Classical 2D and Metabolic Equilibrium in 3D Environments , 2014, PloS one.

[23]  Hwan-You Chang,et al.  Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and β1-integrin , 2006, Cell and Tissue Research.

[24]  A. Ivascu,et al.  Diversity of cell-mediated adhesions in breast cancer spheroids. , 2007, International journal of oncology.

[25]  S. Duncan,et al.  Protocol for directed differentiation of human pluripotent stem cells toward a hepatocyte fate , 2014 .